{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:33:07Z","timestamp":1793313187431,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.euroneuro.2010.02.001","type":"journal-article","created":{"date-parts":[[2010,3,5]],"date-time":"2010-03-05T09:43:11Z","timestamp":1267782191000},"page":"310-316","source":"Crossref","is-referenced-by-count":51,"title":["Drug attitude as predictor for effectiveness in first-episode schizophrenia: Results of an open randomized trial (EUFEST)"],"prefix":"10.1016","volume":"20","author":[{"given":"Wolfgang","family":"Gaebel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Riesbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"von Wilmsdorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eske M.","family":"Derks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9 S.","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wulf","family":"R\u00f6ssler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Wolfgang","family":"Fleischhacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2010.02.001_bib1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0920-9964(90)90005-R","article-title":"A depression rating scale for schizophrenics","volume":"3","author":"Addington","year":"1990","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2010.02.001_bib2","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1055\/s-2007-992141","article-title":"Risk factors for medication non-adherence in patients with first episode schizophrenia and related disorders; a prospective five year follow-up","volume":"40","author":"De Haan","year":"2007","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.euroneuro.2010.02.001_bib3","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/01.jcp.0000130554.63254.3a","article-title":"Brief evaluation of medication influences and beliefs: development and testing of a brief scale for medication adherence","volume":"24","author":"Dolder","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2010.02.001_bib4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.schres.2005.06.004","article-title":"The European First Episode Schizophrenia Trial (EUFEST): rationale and design of the trial","volume":"78","author":"Fleischhacker","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2010.02.001_bib5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1600-0447.1993.tb03366.x","article-title":"The St Hans Rating Scale for extrapyramidal syndromes: reliability and validity","volume":"87","author":"Gerlach","year":"1993","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2010.02.001_bib6","series-title":"ECDEU Assessment Manual for Psychopharmacology, revised","first-page":"218","article-title":"Clinical Global Impressions (CGI) Scale","author":"Guy","year":"1976"},{"key":"10.1016\/j.euroneuro.2010.02.001_bib7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1017\/S0033291700050182","article-title":"A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity","volume":"13","author":"Hogan","year":"1983","journal-title":"Psychol. Med."},{"key":"10.1016\/j.euroneuro.2010.02.001_bib8","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1176\/ps.48.9.1107","article-title":"Efficacy versus effectiveness","volume":"48","author":"Hogarty","year":"1997","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.euroneuro.2010.02.001_bib9","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1001\/archpsyc.1989.01810070090014","article-title":"Diagnosing diagnosis","volume":"46","author":"Hsiao","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.02.001_bib10","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(08)60486-9","article-title":"Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial","volume":"371","author":"Kahn","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2010.02.001_bib11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0920-9964(99)00204-2","article-title":"Attitudes towards neuroleptic treatment: reliability and validity of the Attitudes towards Neuroleptic Treatment (ANT) questionnaire","volume":"45","author":"Kampman","year":"2000","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2010.02.001_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0165-1781(02)00030-6","article-title":"Indicators of medication compliance in first-episode psychosis","volume":"110","author":"Kampman","year":"2002","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2010.02.001_bib13","first-page":"28","article-title":"The Positive and Negative Syndrome Scale (PANSS) rating manual","volume":"17","author":"Kay","year":"1986","journal-title":"Soc. Behav. Sci. Doc."},{"key":"10.1016\/j.euroneuro.2010.02.001_bib14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/bmj.312.7027.345","article-title":"Compliance therapy in psychotic patients: randomised controlled trial","volume":"312","author":"Kemp","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.euroneuro.2010.02.001_bib15","doi-asserted-by":"crossref","first-page":"892","DOI":"10.4088\/JCP.v63n1007","article-title":"Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature","volume":"63","author":"Lacro","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.02.001_bib16","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2010.02.001_bib17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00005053-198901000-00008","article-title":"Insight and the clinical outcome of schizophrenic patients","volume":"177","author":"McEvoy","year":"1989","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.euroneuro.2010.02.001_bib18","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.schres.2009.04.018","article-title":"A prospective study of cannabis use as a risk factor for non-adherence and treatment dropout in first-episode schizophrenia","volume":"113","author":"Miller","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2010.02.001_bib19","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.0001-690X.2003.00193.x","article-title":"Clinical correlates of early medication adherence: West London first episode schizophrenia study","volume":"108","author":"Mutsatsa","year":"2003","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2010.02.001_bib20","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.4088\/JCP.v63n1206","article-title":"Predictors of noncompliance in patients with schizophrenia","volume":"63","author":"Perkins","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.02.001_bib21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.schres.2005.10.016","article-title":"Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode","volume":"83","author":"Perkins","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2010.02.001_bib22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4088\/JCP.v69n0114","article-title":"Comparison of Atypicals in First Episode study group.Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study","volume":"69","author":"Perkins","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.02.001_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/002076409904500102","article-title":"Application and results of the Manchester Short Assessment of Quality of Life (MANSA)","volume":"45","author":"Priebe","year":"1999","journal-title":"Int. J. Soc. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.02.001_bib24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/070674370905400106","article-title":"Early predictors of nonadherence to antipsychotic therapy in first-episode psychosis","volume":"54","author":"Rabinovitch","year":"2009","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.02.001_bib25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0920-9964(01)00312-7","article-title":"Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder","volume":"57","author":"Robinson","year":"2002","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2010.02.001_bib26","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/bmj.324.7336.539","article-title":"The architecture of diagnostic research","volume":"324","author":"Sackett","year":"2002","journal-title":"BMJ"},{"issue":"334, suppl","key":"10.1016\/j.euroneuro.2010.02.001_bib27","first-page":"81","article-title":"The UKU Side Effect Rating Scale: scale for the registration of unwanted effects of psychotropics","volume":"76","year":"1987","journal-title":"Acta Psychiatr. Scand."},{"issue":"suppl 20","key":"10.1016\/j.euroneuro.2010.02.001_bib28","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.02.001_bib29","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.schres.2006.03.021","article-title":"The five-factor model of the Positive and Negative Syndrome Scale II: a ten-fold cross-validation of a revised model","volume":"85","author":"van der Gaag","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2010.02.001_bib30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1034\/j.1600-0447.2000.102003203.x","article-title":"Medication adherence in psychosis: predictors and impact on outcome. A 2-year follow-up of first-admitted subjects","volume":"102","author":"Verdoux","year":"2000","journal-title":"Acta Psychiatr. Scand."},{"issue":"Suppl 14","key":"10.1016\/j.euroneuro.2010.02.001_bib31","first-page":"14","article-title":"Understanding and addressing adherence issues in schizophrenia: from theory to practice","volume":"68","author":"Weiden","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.02.001_bib32","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/schbul\/20.2.297","article-title":"Rating of medication influences (ROMI) scale in schizophrenia","volume":"20","author":"Weiden","year":"1994","journal-title":"Schizophr. Bull."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X10000209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X10000209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,26]],"date-time":"2019-05-26T17:10:01Z","timestamp":1558890601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X10000209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0924977X10000209"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2010.02.001","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}